Developer docs
API playgroundTry for free, no card

Search company profiles

Medicover

Full company profile

uuid0004seg

Namestring
Medicover
Legal namestring
Medicover AB (publ)
Websiteurl
medicover.com
Company typeenum
Public
Founded yearint
1995
Descriptiontext

Medicover AB (publ) is a Stockholm-listed international healthcare and diagnostic services provider founded in 1995, operating across 18+ countries with 49,000+ employees. The business is organized into two divisions: Diagnostic Services, which runs 1,046 blood collection centers and laboratory facilities serving over 65,000 referring physicians across Central and Eastern Europe, Turkey, and other markets under the Synevo brand; and Healthcare Services, which delivers hospitals, clinics, dental care, fertility treatments, sports medicine, and employer healthcare programs, including 26 hospitals with approximately 6,000 beds in India under Medicover Hospitals.

The company's core technology stack combines high-throughput laboratory diagnostics (clinical chemistry, hematology, microbiology, molecular diagnostics, genetics, and pathology) with proprietary genetic testing capabilities developed through its 87.2%-owned subsidiary NIPD Genetics, including Non-Invasive Prenatal Testing (NIPT) and an MRD assay for cancer diagnostics scheduled for commercialization in H2 2026. Medicover also distributes AI-powered long-term ECG monitoring technology through a partnership with Kardi AI and operates Medicover Integrated Clinical Services (MICS), providing clinical trial operational services to pharmaceutical and biotech clients across Europe, the United States, and Asia-Pacific.

Medicover generates revenue primarily through fee-for-service arrangements with individual patients, recurring employer healthcare subscriptions with corporate customers, and usage-based diagnostic testing billed to referring physicians and clinics. In 2025 the business served 15.8 million people through Diagnostic Services and more than 14.4 million through Healthcare Services, with FY2025 revenue of €2.38 billion and Q4 2025 organic growth of 10.6%. The company has stated a three-year financial target of revenue exceeding €3.25 billion and adjusted organic EBITDA above €600 million by 2028.

Short descriptiontext

Medicover is a Stockholm-listed international healthcare and diagnostic services provider operating across 18+ countries, serving 30+ million patients annually through Diagnostic Services (lab testing for 65,000+ referring physicians) and Healthcare Services (hospitals, clinics, fertility, dental, and employer health programs), with major presence in Central and Eastern Europe and India.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1,001–5,000
akta.pro rankint
HeadquartersStockholm, Sweden
HQ citystring
Stockholm
HQ countrystring
Sweden
HQ regionstring
Europe
Markets served

Serves global market

Offices7 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
diagnostic laboratory services, healthcare services, hospital services, genetic testing services, clinical trial services
NAICS code2 codes
  • Medical and Diagnostic Laboratories62151
  • Offices of Physicians62111
SIC code2 codes
  • Services-Health Services8000
  • Services-Medical Laboratories8071
Product category
Healthcare and Diagnostic Services
Social media profiles2 records
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Healthcare Services
TypeSubscription Recurring
Description

Medicover's Healthcare Services division provides hospital and clinical services including fertility, sports medicine, dental care, and general healthcare. Services are provided to corporate customers (employer healthcare plans) and individual patients. Revenue is generated through fee-for-service arrangements. The division achieved organic growth of 11% and margin expansion to 17% in 2025.

seekingalpha.com
2Diagnostic Services
TypeUsage Based
Description

Medicover's Diagnostic Services division provides laboratory diagnostic services including routine tests, specialized testing, and genetic diagnostics. Services are provided to over 65,000 referring physicians. The division achieved double-digit growth across all fee-for-service markets with margins improving to 17.3% in 2025.

seekingalpha.com
3Integrated Clinical Services (MICS)
TypeProfessional Services
Description

Medicover Integrated Clinical Services (MICS) provides clinical trial operational experience and local networks for global multinational clinical trials across Europe, the United States, and the Asia-Pacific region, partnering with GCCL for specimen analysis capabilities.

koreabiomed.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Infrastructure, Technology or R&D, Supply Chain, Marketing or Sales
Pricing details1 tier
1Private healthcare expenditure channeled through Medicover
ModelSubscriptionBilling cadencePay-as-you-go
Notes

Total private healthcare expenditure channeled through Medicover in 2025 amounted to 1,874 MEUR. Services include diagnostic tests, hospital services, and preventive care provided to corporate customers and individual patients.

medicover.com
GTM typeB2B and B2C
B2B and B2C
Offering typeServices
Services
Brand1 of 4 records shown
1Medicover Genetics
Description

Genetic testing and diagnostics services including MRD assays for cancer detection

medicover-genetics.com
+3 more records
Core offering1 text field

Medicover is a specialised provider of diagnostic and healthcare services operating through two divisions. Diagnostic Services delivers laboratory testing, genetic testing, histopathology, and clinical trial services to referring physicians and patients. Healthcare Services delivers hospital care, outpatient clinics, fertility, dental, sports medicine, and employer healthcare programs to corporate customers and individual patients across Central and Eastern Europe and India.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • Employees covered by Medicover healthcare have 3.5 more healthy and productive work days per year compared to general population
+4 more records
Product and service9 records
1Diagnostic Services (Synevo and affiliated laboratories)
CategoryLaboratory diagnostic services
Description

Centralized laboratory diagnostic testing services including routine and specialized tests, histopathology, microbiology, molecular diagnostics, and pathology, delivered to referring physicians, hospitals, and patients across Central and Eastern Europe and India.

2Healthcare Services (Hospitals, Clinics, Employer Healthcare)
CategoryHospital and clinical services
Description

Vertically integrated healthcare delivery including hospitals, outpatient clinics, fertility treatments, dental care, sports medicine, and employer-sponsored healthcare programs for individual patients and corporate customers across Europe and India.

3Medicover Genetics (MRD Assay and Genetic Testing)
CategoryGenetic and molecular diagnostics
Description

Genetic testing services including Non-Invasive Prenatal Testing (NIPT) for unborn children and an MRD assay using ctDNA detection for early indication of disease progression in non-small cell lung cancer, sold to clinicians, hospitals, and patients through the Medicover Genetics brand.

4Medicover Integrated Clinical Services (MICS)
CategoryClinical trial services
Description

Clinical trial operational services for global pharmaceutical and biotech sponsors across Europe, US, and Asia-Pacific, providing local networks, clinical operations, and specimen analysis in partnership with GCCL.

5Medicover Fertility (Invimed, Wunschkinder Berlin, Ovoria)
CategoryFertility and reproductive medicine
Description

IVF, fertility treatments, and reproductive medicine services delivered through Medicover Fertility and acquired brands across multiple European markets.

6MeinDentist Dental Clinics
CategoryDental services
Description

Dental care services delivered through MeinDentist clinics in Germany, serving both insured and private-pay patients.

7Sports Medicine and Rehabilitation (Rehasport)
CategorySports medicine and rehabilitation
Description

Sports medicine, physiotherapy, and rehabilitation services for patients recovering from injury or seeking performance and preventive care.

8Histopathology Services
CategoryHistopathology and pathology diagnostics
Description

Tissue-based diagnostic and pathology services supporting hospitals, oncologists, and referring physicians with cancer diagnosis and disease characterization.

9AI-Powered Long-term ECG Monitoring (Kardi AI)
CategoryCardiac diagnostics and remote monitoring
Description

Long-term ECG monitoring service using Kardi AI technology, offered through Medicover's network for atrial fibrillation detection in post-stroke and at-risk patients.

Scale indicator11 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-02-10
Description

GCCL and Medicover Integrated Clinical Services (MICS) signed a memorandum of understanding to collaborate on multinational clinical trial services across Europe, United States, and Asia-Pacific region. The partnership combines MICS's clinical trial operational experience and local networks with GCCL's specimen analysis capabilities and project management expertise across Asia including Korea.

Recent move8 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

One of Europe's largest medical diagnostic services providers operating clinical laboratories across multiple countries. Direct competitor to Medicover's Synevo network in CEE and Germany; Medicover itself acquired SYNLAB's Romanian operations and assets in five other CEE countries in 2025, underscoring direct overlap.

TypeBroad incumbent
Description

Global medical diagnostics company providing laboratory and radiology services across Australia, Europe, and North America. Highly comparable to Medicover's Diagnostic Services division given its scale, multi-country laboratory footprint, and referring-physician network, but operates at much larger scale and broader geographic scope.

TypeDirect peer
Description

European clinical laboratory and diagnostics provider operating across more than 15 countries with a network of laboratories and collection centers. Direct competitor to Medicover/Synevo in Western and Central Europe, with similar B2B focus on referring physicians and similar clinical service portfolio.

TypeBroad incumbent
Description

One of the largest clinical laboratory networks in the United States, offering routine, esoteric, and genetic testing services to referring physicians, hospitals, and patients. Highly comparable business model to Medicover's Diagnostic Services division (Synevo), though materially larger and focused on the US market rather than CEE.

TypeBroad incumbent
Description

Major US-based clinical laboratory network providing routine and specialty diagnostics to physicians, hospitals, and biopharma. Closely comparable to Medicover's Synevo lab division in service mix (clinical chemistry, molecular/genetic, esoteric testing) and B2B physician channel, though far larger and primarily US-centric.

TypeRegional player
Description

One of India's largest hospital chains with a broad multi-specialty hospital network across the country. Direct competitor to Medicover Hospitals India, particularly in southern states like Telangana and Andhra Pradesh where Medicover has built its 6,000-bed platform.

7Fortis Healthcare
TypeRegional player
Description

Leading Indian multi-specialty hospital chain operated under IHH Healthcare. Comparable to Medicover Hospitals India in terms of inpatient services, geographic spread across India, and corporate healthcare delivery model — both compete for tertiary-care patients in major Indian metros.

TypeBroad incumbent
Description

Global vertically integrated healthcare services company operating hospitals, dialysis clinics, and care delivery networks primarily across Europe. Comparable to Medicover's broader healthcare services portfolio given its pan-European clinical care footprint, though Fresenius is far larger and more focused on dialysis and specialty services.

TypeBroad incumbent
Description

One of the world's largest private hospital groups, with significant operations in Turkey (Acibadem), India (Fortis), and Southeast Asia. Comparable to Medicover in operating multi-country private hospital networks focused on premium and corporate healthcare customers, with particular overlap in Turkish and Indian markets.

TypeEmerging player
Description

Europe-based genetic testing and rare disease diagnostics company focused on hereditary disease screening and multi-omic analysis. Comparable to Medicover Genetics (post-NIPD Genetics acquisition) in the European clinical genetics and NIPT space, though materially smaller and more specialized.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI capability1 record

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles9 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries14 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds3 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A7 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Medicover

Healthcare and Diagnostic Servicesmedicover.com

Medicover is a Stockholm-listed international healthcare and diagnostic services provider operating across 18+ countries, serving 30+ million patients annually through Diagnostic Services (lab testing for 65,000+ referring physicians) and Healthcare Services (hospitals, clinics, fertility, dental, and employer health programs), with major presence in Central and Eastern Europe and India.

What Medicover does

Medicover AB (publ) is a Stockholm-listed international healthcare and diagnostic services provider founded in 1995, operating across 18+ countries with 49,000+ employees. The business is organized into two divisions: Diagnostic Services, which runs 1,046 blood collection centers and laboratory facilities serving over 65,000 referring physicians across Central and Eastern Europe, Turkey, and other markets under the Synevo brand; and Healthcare Services, which delivers hospitals, clinics, dental care, fertility treatments, sports medicine, and employer healthcare programs, including 26 hospitals with approximately 6,000 beds in India under Medicover Hospitals.

The company's core technology stack combines high-throughput laboratory diagnostics (clinical chemistry, hematology, microbiology, molecular diagnostics, genetics, and pathology) with proprietary genetic testing capabilities developed through its 87.2%-owned subsidiary NIPD Genetics, including Non-Invasive Prenatal Testing (NIPT) and an MRD assay for cancer diagnostics scheduled for commercialization in H2 2026. Medicover also distributes AI-powered long-term ECG monitoring technology through a partnership with Kardi AI and operates Medicover Integrated Clinical Services (MICS), providing clinical trial operational services to pharmaceutical and biotech clients across Europe, the United States, and Asia-Pacific.

Medicover generates revenue primarily through fee-for-service arrangements with individual patients, recurring employer healthcare subscriptions with corporate customers, and usage-based diagnostic testing billed to referring physicians and clinics. In 2025 the business served 15.8 million people through Diagnostic Services and more than 14.4 million through Healthcare Services, with FY2025 revenue of €2.38 billion and Q4 2025 organic growth of 10.6%. The company has stated a three-year financial target of revenue exceeding €3.25 billion and adjusted organic EBITDA above €600 million by 2028.

Medicover firmographics

Firmographics
Name
Medicover
Legal name
Medicover AB (publ)
Website
https://medicover.com
Company type
Public
Founded year
1995
Operating status
Operating
Headcount range
1,001–5,000 employees
Short description
Medicover is a Stockholm-listed international healthcare and diagnostic services provider operating across 18+ countries, serving 30+ million patients annually through Diagnostic Services (lab testing for 65,000+ referring physicians) and Healthcare Services (hospitals, clinics, fertility, dental, and employer health programs), with major presence in Central and Eastern Europe and India.
Ownership category
akta.pro rank

Where Medicover is headquartered

Location

Headquarters

HQ city
Stockholm
HQ country
Sweden
HQ region
Europe

Offices7 records

Markets served

Medicover business model

Business model
GTM type
B2B and B2C
Offering type
Services
Cost components
Personnel, Operations, Infrastructure, Technology or R&D, Supply Chain, Marketing or Sales

Revenue model

  1. Healthcare Services: Medicover's Healthcare Services division provides hospital and clinical services including fertility, sports medicine, dental care, and general healthcare. Services are provided to corporate customers (employer healthcare plans) and individual patients. Revenue is generated through fee-for-service arrangements. The division achieved organic growth of 11% and margin expansion to 17% in 2025.
  2. Diagnostic Services: Medicover's Diagnostic Services division provides laboratory diagnostic services including routine tests, specialized testing, and genetic diagnostics. Services are provided to over 65,000 referring physicians. The division achieved double-digit growth across all fee-for-service markets with margins improving to 17.3% in 2025.
  3. Integrated Clinical Services (MICS): Medicover Integrated Clinical Services (MICS) provides clinical trial operational experience and local networks for global multinational clinical trials across Europe, the United States, and the Asia-Pacific region, partnering with GCCL for specimen analysis capabilities.

Pricing tiers

ModelBillingPrice
SubscriptionPay-as-you-goPrivate healthcare expenditure channeled through Medicover

Go-to-market motion2 records

Distribution channels4 records

Marketing channels4 records

Medicover product offering

Product offering

Core offering

Medicover is a specialised provider of diagnostic and healthcare services operating through two divisions. Diagnostic Services delivers laboratory testing, genetic testing, histopathology, and clinical trial services to referring physicians and patients. Healthcare Services delivers hospital care, outpatient clinics, fertility, dental, sports medicine, and employer healthcare programs to corporate customers and individual patients across Central and Eastern Europe and India.

Differentiator

Problem solved

Functional benefit

Brands

  • Medicover Genetics: Genetic testing and diagnostics services including MRD assays for cancer detection
  • Medicover Integrated Clinical Services (MICS)
  • Synevo
  • Medicover Foundation

Products and services

  • Diagnostic Services (Synevo and affiliated laboratories) Centralized laboratory diagnostic testing services including routine and specialized tests, histopathology, microbiology, molecular diagnostics, and pathology, delivered to referring physicians, hospitals, and patients across Central and Eastern Europe and India.
  • Healthcare Services (Hospitals, Clinics, Employer Healthcare) Vertically integrated healthcare delivery including hospitals, outpatient clinics, fertility treatments, dental care, sports medicine, and employer-sponsored healthcare programs for individual patients and corporate customers across Europe and India.
  • Medicover Genetics (MRD Assay and Genetic Testing) Genetic testing services including Non-Invasive Prenatal Testing (NIPT) for unborn children and an MRD assay using ctDNA detection for early indication of disease progression in non-small cell lung cancer, sold to clinicians, hospitals, and patients through the Medicover Genetics brand.
  • Medicover Integrated Clinical Services (MICS) Clinical trial operational services for global pharmaceutical and biotech sponsors across Europe, US, and Asia-Pacific, providing local networks, clinical operations, and specimen analysis in partnership with GCCL.
  • Medicover Fertility (Invimed, Wunschkinder Berlin, Ovoria) IVF, fertility treatments, and reproductive medicine services delivered through Medicover Fertility and acquired brands across multiple European markets.
  • MeinDentist Dental Clinics Dental care services delivered through MeinDentist clinics in Germany, serving both insured and private-pay patients.
  • Sports Medicine and Rehabilitation (Rehasport) Sports medicine, physiotherapy, and rehabilitation services for patients recovering from injury or seeking performance and preventive care.
  • Histopathology Services Tissue-based diagnostic and pathology services supporting hospitals, oncologists, and referring physicians with cancer diagnosis and disease characterization.
  • AI-Powered Long-term ECG Monitoring (Kardi AI) Long-term ECG monitoring service using Kardi AI technology, offered through Medicover's network for atrial fibrillation detection in post-stroke and at-risk patients.

Quantifiable outcome

  • Employees covered by Medicover healthcare have 3.5 more healthy and productive work days per year compared to general population
  • +4 more outcomes

Companies that use Medicover

Customer profile

Named customers2 records

Segments3 records

Ideal customer profiles4 records

Medicover technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability1 record

Feature3 records

Medicover partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • GCCL (Global Clinical Laboratory)coreStrategic or Co-development Partner · 10 February 2026GCCL and Medicover Integrated Clinical Services (MICS) signed a memorandum of understanding to collaborate on multinational clinical trial services across Europe, United States, and Asia-Pacific region. The partnership combines MICS's clinical trial operational experience and local networks with GCCL's specimen analysis capabilities and project management expertise across Asia including Korea.

Scale indicators11 records

Recent moves8 records

Expansion highlights6 records

Medicover competitors and assessment

Company assessment

Direct peers

  • Synlab: One of Europe's largest medical diagnostic services providers operating clinical laboratories across multiple countries. Direct competitor to Medicover's Synevo network in CEE and Germany; Medicover itself acquired SYNLAB's Romanian operations and assets in five other CEE countries in 2025, underscoring direct overlap.
  • Unilabs: European clinical laboratory and diagnostics provider operating across more than 15 countries with a network of laboratories and collection centers. Direct competitor to Medicover/Synevo in Western and Central Europe, with similar B2B focus on referring physicians and similar clinical service portfolio.

Broad incumbents

  • Sonic Healthcare: Global medical diagnostics company providing laboratory and radiology services across Australia, Europe, and North America. Highly comparable to Medicover's Diagnostic Services division given its scale, multi-country laboratory footprint, and referring-physician network, but operates at much larger scale and broader geographic scope.
  • Quest Diagnostics: One of the largest clinical laboratory networks in the United States, offering routine, esoteric, and genetic testing services to referring physicians, hospitals, and patients. Highly comparable business model to Medicover's Diagnostic Services division (Synevo), though materially larger and focused on the US market rather than CEE.
  • Labcorp (Laboratory Corporation of America): Major US-based clinical laboratory network providing routine and specialty diagnostics to physicians, hospitals, and biopharma. Closely comparable to Medicover's Synevo lab division in service mix (clinical chemistry, molecular/genetic, esoteric testing) and B2B physician channel, though far larger and primarily US-centric.
  • Fresenius Medical Care: Global vertically integrated healthcare services company operating hospitals, dialysis clinics, and care delivery networks primarily across Europe. Comparable to Medicover's broader healthcare services portfolio given its pan-European clinical care footprint, though Fresenius is far larger and more focused on dialysis and specialty services.
  • IHH Healthcare (Acibadem): One of the world's largest private hospital groups, with significant operations in Turkey (Acibadem), India (Fortis), and Southeast Asia. Comparable to Medicover in operating multi-country private hospital networks focused on premium and corporate healthcare customers, with particular overlap in Turkish and Indian markets.

Regional players

  • Apollo Hospitals Enterprise: One of India's largest hospital chains with a broad multi-specialty hospital network across the country. Direct competitor to Medicover Hospitals India, particularly in southern states like Telangana and Andhra Pradesh where Medicover has built its 6,000-bed platform.
  • Fortis Healthcare: Leading Indian multi-specialty hospital chain operated under IHH Healthcare. Comparable to Medicover Hospitals India in terms of inpatient services, geographic spread across India, and corporate healthcare delivery model — both compete for tertiary-care patients in major Indian metros.

Emerging players

  • Centogene: Europe-based genetic testing and rare disease diagnostics company focused on hereditary disease screening and multi-omic analysis. Comparable to Medicover Genetics (post-NIPD Genetics acquisition) in the European clinical genetics and NIPT space, though materially smaller and more specialized.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

Medicover social profiles

Digital presence

Medicover financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Medicover leadership team

Management profile

Number of profiles

Profiles9 records

Medicover subsidiaries and ownership

Company hierarchy

Subsidiaries14 records

Medicover funding detail

Funding detail

Funding overview

Funding rounds3 records

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Medicover M&A and investment

M&A and investment

M&A7 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Medicover

What does Medicover do?

Medicover is a specialised provider of diagnostic and healthcare services operating through two divisions. Diagnostic Services delivers laboratory testing, genetic testing, histopathology, and clinical trial services to referring physicians and patients. Healthcare Services delivers hospital care, outpatient clinics, fertility, dental, sports medicine, and employer healthcare programs to corporate customers and individual patients across Central and Eastern Europe and India.

Is Medicover a public or private company?

Medicover is a public company. It is classified as public and is currently operating.

When was Medicover founded?

Medicover was founded in 1995. It employs 1,001 to 5,000 people.

Where is Medicover based?

Medicover is headquartered in Stockholm, Sweden, in the Europe region.

How does Medicover make money?

Three revenue lines are on record. Healthcare Services are the primary driver. The others are diagnostic Services and integrated Clinical Services (MICS).

Who are Medicover's main competitors?

Direct peers on record are Synlab and Unilabs. Broad incumbents are Sonic Healthcare, Quest Diagnostics, Labcorp (Laboratory Corporation of America), Fresenius Medical Care and IHH Healthcare (Acibadem). Regional players are Apollo Hospitals Enterprise and Fortis Healthcare. Centogene is listed as an emerging player.

Does Medicover have an API?

No public API is recorded for Medicover.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Investing.comMedicover at Jefferies Global Healthcare Conference: focus shifts to europeMedicover reported Q3 double-digit organic growth and margin expansion, with EBIT margins up 22%. It plans to complete its India divestment in Q4 2024, becoming debt-free and focusing on Poland, Romania, and Germany. Management expects near-term pressure from German reimbursement changes and Romania's weak membership trend, with conditions improving later in 2027.Simply Wall StHow Investors May Respond To Medicover (OM:MCOV B) Earnings GrowthMedicover reported Q3 2026 sales of €570.8 million and net income of €25.7 million, with basic EPS of €0.162. For the first nine months of 2026, net income grew faster than revenue, supporting a narrative of mix and efficiency. The company projects €3.2 billion revenue and €173.2 million earnings by 2029, though earnings are forecast to decline on average over the next three years.Seeking AlphaMedicover AB (publ) (MCVEY) Q3 2026 Earnings Call TranscriptMedicover reported Q3 2026 results, citing a seventh consecutive quarter of year-on-year margin improvement. The company confirmed its EUR 1.2 billion India divestment, expecting to receive about EUR 740 million from its 66.1% stake, with the deal closing in November or Q4.TradingViewMCOV_B: Organic growth and margin gains continued as India’s sale reshapes future investment capacityMedicover AB reported continuing-operations organic revenue growth of 8% and EBIT up 22% in Q3 2026, with margins improving for a seventh straight quarter. The India sale is expected to provide approximately €740 million, while reimbursement and membership pressures remain near-term risks.Investing.comEarnings call transcript: Medicover slips on q3 2026 EPS miss, shares fallMedicover reported Q3 2026 EPS of just over EUR 0.16, missing the $0.1732 forecast, while revenue rose 6% on a continuing basis. Organic revenue grew 8%, EBIT rose 22% to EUR 49.3 million, and the company expects EUR 740 million from its India sale, closing in November 2026.Investing.comWhy is Medicover stock sliding today?Medicover's stock fell 2.7% after Q3 revenue of €570.8M missed the €604.4M consensus, with adjusted EBITDA and net profit also below estimates. The company cited deteriorating reimbursement and tariff changes in Poland, Germany, and Romania as near-term pressures, while the India hospital sale to KKR was reiterated but already priced in.YahooMedicover shares down 3% as Q3 revenue misses estimates on reimbursement weaknessMedicover shares fell 3% after Q3 revenue of €570.8 million missed the €604.4 million consensus, while operating profit rose 22% to €49.3 million. The company cited public reimbursement weakness and tariffs, and announced the sale of its Indian hospital business for about €740 million, expected to close in Q4.Dagens industriMedicovers resultat i linje med förväntningarnaMedicover reported Q3 2026 results in line with expectations, with organic growth of 8 percent. The company's CEO John Stubbington called the quarter eventful. The report was published on 4 November 2026.BusinessLineIndia PE/VC inflows surge 46% y-o-y to $17.1 billion in Q3 2026: ReportIndia's PE/VC inflows hit $17.1 billion in Q3 2026, up 46% year-on-year, while deal volumes fell 9% to 348 transactions. Large deals drove 76% of investment, with KKR's Medicover India acquisition at $1.4 billion leading. Fundraising closed at $6.4 billion across 32 funds.YahooMedicover (OM:MCOV B) Stock Looks Above Fair Value At Current EarningsMedicover's stock at SEK 276 trades at a P/E of 44.4x, well above the healthcare sector average of 18.8x. The valuation is near peer pack levels, but a tailored model suggests a lower P/E, indicating the stock is overvalued on earnings.